Launching a Successful Commercial Gene Therapy: Bluebird Bio’s Journey from Clinical Development to Market
Time: 3:30 pm
day: Conference Day Two pt 2
Details:
- Insights into Bluebird Bio’s strategic choices in advancing multiple gene therapies simultaneously, addressing diverse therapeutic areas, and navigating the challenges of clinical development
- A look at Bluebird Bio’s approach to securing regulatory approvals across different markets, leveraging innovative trial designs and close regulatory partnerships to streamline the pathway to approval
- Key lessons on preparing for large-scale manufacturing, optimizing market access strategies, and ensuring patient and provider readiness to drive the successful adoption of their therapies
